Effect of Cannabis Legalization on US Autism Incidence and Medium Term Projections

Journal Title: Clinical Pediatrics: Open Access - Year 2019, Vol 4, Issue 2

Abstract

Objective: In that cannabis use has been linked with the development of autism spectrum disorder like conditions in gestationally exposed children, we set out to explore the extent to which rising cannabis use might contribute to the rising autism epidemic. Methods: Datasets from US Department of Education Individuals with Disabilities Act (IDEA), National Survey of Drug Use and Health, and CDC’s Autism and Developmental Disabilities Monitoring (ADDM) Network were investigated. Data on legal status was derived from SAMHSA. Results: IDEA had N=1,023 and ADDM N=87. Modelling of IDEA consistently showed that models quadratic-intime out-performed linear-only models (ANOVA p<2.0x10-16). In both datasets liberalization of cannabis legislation was associated with increased ASD (p<10-9 and p<0.05 respectively). Slopes of: ASD vs. time, Cannabis vs. time and ASD vs. cannabis curves were shown to be related on graphical analysis by geofacet plots and tanglegrams (entanglement=0.3326). CDC’s ADDM network quoted US autism incidence 168/10,000 in 2014. IDEA projections indicated rates 108.57, 131.67 and 166.49 in cannabis-illegal, -medical and -decriminalized states rising exponentially to 282.37, 396.91 and 455.54 by 2030. Conclusion: ASD is the commonest form of cannabis-associated clinical teratology. Using two independent datasets and two categorization methods we confirmed that medical, decriminalized and legal cannabis regimes are associated with higher rates of ASD than illegal ones. Findings are consistent with molecular, cellular and epigenetic mechanisms. Formerly quadratic regression curves become exponential when projected forwards to 2030; predict a lower quantum than the 2014 ADDM CDC figure; and indicate a 60% excess of cases in legal states by 2030.

Authors and Affiliations

Albert q Stuart Reece, Gary Kenneth Hulse

Keywords

Related Articles

Comparison of Homozygous for Delta F508 Mutation Nutritional Status, Lung Function Outcomes, Bacterial Growth, Antibiotic Treatments and Therapeutic Outcomes between the Amish and Non-Amish in a Single Pediatric Cystic Fibrosis Centre: A Retrospective Case-Controlled Study

There exists evident differences in the health and the care received of the Amish people in comparison to the general population. Amish patients were 100% homozygous for delta F508 mutation...

The Outbreak of Acinetobacter baumannii over a 19 month Period in a Teaching Hospital Neonatal Intensive Care Unit

Objective: We investigated a long outbreak of a nosocomial infection of Acinetobacter baumannii (A. baumannii) in the Neonatal Intensive Care Unit (NICU) of Vali-Asr Teaching Hospital in Tehran, Iran. Methods: Within 1...

Epidemiological Associations of Various Substances and Multiple Cannabinoids with Autism in USA

Introduction: Autistic Spectrum Disorder (ASD) is increasing in across USA. Paediatricians and physicians in both Colorado and Australia continue to see high caseloads however this prevalence uptick remains largely unexp...

Effect of Cannabis Legalization on US Autism Incidence and Medium Term Projections

Objective: In that cannabis use has been linked with the development of autism spectrum disorder like conditions in gestationally exposed children, we set out to explore the extent to which rising cannabis use might con...

Download PDF file
  • EP ID EP674629
  • DOI -
  • Views 250
  • Downloads 0

How To Cite

Albert q Stuart Reece, Gary Kenneth Hulse (2019). Effect of Cannabis Legalization on US Autism Incidence and Medium Term Projections. Clinical Pediatrics: Open Access, 4(2), 1-17. https://europub.co.uk/articles/-A-674629